[ALPHA-METHYLDOPA, ALPHA-METHYLDOPA AND HYDROCHLOROTHIAZIDE, AND A PLACEBO IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION: "DOUBLE-BLIND" TEST].
D000959:Antihypertensive Agents; D035843:Biomedical Research; D001766:Blindness; D004311:Double-Blind Method; D006852:Hydrochlorothiazide; D006973:Hypertension; D008750:Methyldopa; D010600:Pharmacology; D010919:Placebos; D019987:Persons with Visual Disabilities
D000959:Antihypertensive Agents; D010919:Placebos; D006852:Hydrochlorothiazide; D008750:Methyldopa
ANTIHYPERTENSIVE AGENTS; CLINICAL RESEARCH; HYDROCHLOROTHIAZIDE; HYPERTENSION; PHARMACOLOGY; PLACEBOS
ALFAMETILDOPA, ALFAMETILDOPA-HIDROCLOROTIAZIDA Y PLACEBO EN PACIENTES CON HIPERTENSI'ON ARTERIAL SIST'EMICA: PRUEBA DEL "DOBLE CIEGO".